Modern Marketer helps science-led companies decide what to take to market, who will pay first, and how to convert early traction into a repeatable commercial motion-grounded in real buyer signal.
Preclinical or pilot-ready — but unclear how to lead commercially?
If the science is strong but the commercial story is still forming, we help you choose the lead use case, define the first paying buyer, and articulate a narrative that holds up with partners and investors.
From scientific validation to commercial direction
We believe early commercial decisions deserve rigor.
For life sciences and medical device companies, determining how to lead commercially is as consequential as proving feasibility. Without structure, execution amplifies uncertainty.
Catalyst is how we address this systematically: a productized engagement designed to clarify how science should lead commercially.
Where commercial clarity begins
You may be here if:- You have multiple possible markets or buyer groups, but no clear lead priority
- Early interest or pilots are not converting into committed revenue
- Positioning shifts across product, sales, and marketing
- Investors or leadership need a sharper “why this, why now”
- GTM activity has started before the decision is truly locked
When these conditions persist, the risk is not lack of effort—but misallocated focus
Why teams bring us in?
Because science-led products do not fail for the same reasons as generic software. The market is harder to choose, the buyer is harder to convince, and the commercial narrative has to hold up with investors, partners, and operators at the same time. Modern Marketer works upstream of execution to help teams make that first GTM decision with rigor.
Evidence over internal opinion
We do not begin with channels. We begin with the decision. Through buyer signal, wedge selection, and demand testing, we help teams decide what to take to market before execution scales the wrong message or market.
If you’re about to raise, run pilots, or go to market — don’t guess.
How We Work Over Time
Elevate- Category Strength Over Time
Which commercial emergency are you facing?
Catalyst
Build commercial conviction before you raise, pilot, or launch.
Catalyst is an 8–12 week commercialisation strategy engagement for science-led teams that need to choose their first market, first buyer, proof path, and commercial narrative before they commit resources to GTM execution.
Best when: investors, partners, or your own team are asking, “Which market and buyer should we prioritize first?"
Elevate
Strengthen GTM strategy for scale, partnerships, and category leadership.
Elevate is an ongoing strategic GTM partnership for science-led companies moving beyond early traction and preparing for expansion, strategic partnerships, licensing, board/investor conversations, portfolio decisions, or acquisition-readiness.
Best when: the company has traction, but the commercial story and GTM system need to mature for the next stage.
Launch
Turn GTM clarity into pipeline, pilots, and repeatable revenue motion.
Launch is a 16–18 week execution program for science-led teams that have a buyer thesis but need sharper messaging, outreach, sales assets, account strategy, and conversion systems to turn interest into commercial progress.
Best when: you have conversations, pilots, or pipeline — but traction is not yet repeatable.
The 15-Day GTM Lock-In Sprint is a paid decision sprint for science-led founders facing an urgent milestone — fundraising, investor diligence, demo day, pilot decision, launch, market entry, partner conversation, or board update.
In 15 days, we pressure-test your market, buyer, proof path, positioning, and first revenue motion so you can make a clear commercial decision before committing to a larger GTM build.
Best when: the urgency is real, but the right larger engagement still needs to be scoped.